Immunome Inc. — Director's Dealing 2021

May 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2021-05-24

Reporting Person: Lefenfeld Michael (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-24	Common Stock	P	600	$17.80	Acquired	22822	Direct
2021-05-25	Common Stock	P	2715	$18.44	Acquired	25537	Direct
2021-05-26	Common Stock	P	1335	$19.03	Acquired	26872	Direct

Footnotes

F1: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.38 to $18.52, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

F2: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.66 to $19.43, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.